Periscope Capital’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Periscope Capital’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-362,811	Closed	-$4.06K	–	910
2022 Q4	$4.06K	Hold	362,811	–	–	﹤0.01%	846
2022 Q3	$34K	Buy	362,811 +237,911	+190%	+$25.5K	﹤0.01%	774
2022 Q2	$10K	Hold	124,900	–	–	﹤0.01%	1097
2022 Q1	$25K	Hold	124,900	–	–	﹤0.01%	1087
2021 Q4	$67K	Buy	+124,900	New	+$70.8K	﹤0.01%	888

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Periscope Capital's IBER.WS Position: Q1 2023 in Review

Periscope Capital sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 362,811 shares — an estimated $4.06K sold.

Periscope Capital first reported a position in IBER.WS in Q4 2021 and held it in 5 quarters. The position peaked at $67K in Q4 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Periscope Capital reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Periscope Capital sold 362,811 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $4.06K.
Periscope Capital first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2021 and held it in 5 quarters.
Periscope Capital's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $67K in Q4 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Periscope Capital's 13F filing for Q1 2023, filed 12 May 2023.